Reducing the amount of acetaminophen in opioids and combination medications appears to be safe for the liver.

Published Date: 13 Mar 2023

The United States Food and Drug Administration (FDA) has ordered a ban on the use of acetaminophen in combination with acetaminophen and opioids...

Read Full News

Latest News

Is Ketamine for Depression Moving Too Fast on Weak Data?

Ketamine has been hailed as a fast-acting, effective treatment for major depression. But new research questions whether the drug lives up to its hype.

FDA Psychiatry Roundup: April 2026

A monthly snapshot of FDA activity involving therapies used in the prevention and treatment of psychiatric conditions.

IA Thrombolysis After Thrombectomy: More Uncertainty

The TECNO trial finds no clear reperfusion benefit from intra-arterial thrombolysis after thrombectomy in acute ischemic stroke, raising fresh doubts about the strategy.

Aging in Hospital Medicine: How to Retain Older Hospitalists

The schedule and demanding nature of the job make hospitalist jobs more difficult as you age. Some systems are trying to help.

Soccer-Study Warns Of Dangerous Heat At 2026 World Cup as Climate Risks Grow

Football's global players' union renewed concerns on Thursday about heat at the 2026 World Cup after scientists warned the likelihood of dangerous temperatures for players...

Is Flare Prophylaxis Always Needed When Starting Gout Drugs?

There are divided opinions over whether anti-inflammatory drugs should always be used when initiating urate-lowering therapy for gout. Would a ‘pill in the pocket’ approach be better?

Todays Updates

Antibiotic Stewardship: Five Tips to Reduce Resistance

Clinicians continue prescribing antibiotics unnecessarily despite growing evidence supporting shorter, targeted, and reassessed treatment strategies.

France Expands 2026 Vaccination Rules Amid Resurgence

Nearly 300 experts warn that rising vaccine misinformation is reversing gains — measles and meningococcal infections are resurging while France updates the 2026 schedule.

Can Concurrent Boost Safely Shorten Breast Cancer Radiation?

Patients were randomly assigned 1:1 to receive either concurrent radiation dose escalation to the lumpectomy cavity during whole-breast irradiation or sequential boost after whole-breast irradiation.

FDA Expands Use of T-DXd in Early HER2+ Breast Cancer

The agency OK’d trastuzumab deruxtecan for two indications in HER2-positive early-stage breast cancer, covering both the neoadjuvant and adjuvant settings.

Todays Updates

Antibiotic Stewardship: Five Tips to Reduce Resistance

Clinicians continue prescribing antibiotics unnecessarily despite growing evidence supporting shorter, targeted, and reassessed treatment strategies.

France Expands 2026 Vaccination Rules Amid Resurgence

Nearly 300 experts warn that rising vaccine misinformation is reversing gains — measles and meningococcal infections are resurging while France updates the 2026 schedule.

Can Concurrent Boost Safely Shorten Breast Cancer Radiation?

Patients were randomly assigned 1:1 to receive either concurrent radiation dose escalation to the lumpectomy cavity during whole-breast irradiation or sequential boost after whole-breast irradiation.

FDA Expands Use of T-DXd in Early HER2+ Breast Cancer

The agency OK’d trastuzumab deruxtecan for two indications in HER2-positive early-stage breast cancer, covering both the neoadjuvant and adjuvant settings.

Latest News

Ketamine has been hailed as a fast-acting, effective treatment for major depression. But new research questions whether the drug lives up to its hype.

A monthly snapshot of FDA activity involving therapies used in the prevention and treatment of psychiatric conditions.

The TECNO trial finds no clear reperfusion benefit from intra-arterial thrombolysis after thrombectomy in acute ischemic stroke, raising fresh doubts about the strategy.

The schedule and demanding nature of the job make hospitalist jobs more difficult as you age. Some systems are trying to help.

Football's global players' union renewed concerns on Thursday about heat at the 2026 World Cup after scientists warned the likelihood of dangerous temperatures for players...

There are divided opinions over whether anti-inflammatory drugs should always be used when initiating urate-lowering therapy for gout. Would a ‘pill in the pocket’ approach be better?

News All Time

Convicted Former Harvard Scientist Rebuilds Brain Computer Lab in China

An American scientist convicted of lying to U.S. authorities about payments from China while he was at Harvard University has rebuilt his research lab in Shenzhen to pursue...

‘Living’ Database Tracks Psilocybin Trials for Depression

Sypres.io continuously tracks and evaluates psychedelic research, offering an up-to date view of study findings, design, and limitations.

EU Investigates Suspected COVID Procurement Fraud in Romania

EU prosecutors are investigating 1.5 million euros of suspected fraud related to the public procurement of medical equipment in Romania during ⁠the COVID pandemic in 2021.

Hospitalists Are Pivotal in Supporting Homebound Plans

Care coordination, follow-ups, and equipment needs are all part of the discharge plan.

Long Covid Linked to Brain Changes

New brain imaging data on patients with long COVID showed an association with Alzheimer’s disease-related changes.

Why Quality Health Information May Drive Health Outcomes

Widespread use of online medical content and AI tools is reshaping decision-making and raising concerns about misinformation.

Inosine Pranobex Linked to Lower Mortality Risk in COVID

The use of inosine pranobex is associated with a lower risk for mortality in patients with COVID, a new study suggests.

EMA Greenlights Drugs for MS and Spinal Muscular Atrophy

Cenrifki prevents MS disease progression and Itvisma delivers a healthy gene-to-cell nuclei, addressing the root cause of SMA.

Bipolar II Disorder May Raise the Risk for Mortality

Bipolar II disorder is associated with higher all-cause mortality risk in teens and adults than bipolar disorder I or not having either condition, a new study shows.

Loneliness and Isolation: The Hidden Costs of Hospitalization

Adults who are hospitalized often feel lonely and socially isolated.

UK Lawmakers Approve Lifetime Smoking Ban for Today's Under-18s

Children in Britain who are 17 or younger, and anyone born in the future, will never be able to ⁠legally buy cigarettes after lawmakers approved new stricter restrictions on...

How Caring Differently Eases GP Stress Levels

GPs with a patient-centred orientation may experience lower perceived stress, whereas those with a higher number of daily patient contacts may experience higher stress.

Crumbling NHS Hospitals to Face More Years of Risk and Cost

Seven hospitals with dangerous RAAC concrete won't be replaced until 2032-2033, costing up to £140 million extra per year of delay.

COVID’s Cicada Invasion Doesn’t Yet Prompt Concerns

A previously dormant variant appears to evade the current vaccine, but impact remains unclear.

Fast-spreading Measles Outbreak Has Killed At Least 30 in Bangladesh, WHO Says

Bangladesh has confirmed 30 deaths in a measles outbreak that has spread ⁠rapidly across the country, with most of the victims aged under two, the World Health ⁠Organization...

Digital Twin Platform Comes to Orthopedics to Optimize Care

The platform will be used to build virtual anatomic replicas of patients to run simulations and plan surgery, make intraoperative decisions, and predict outcomes across treatment options.

Recommended News For You

The origin of BPH and prostate cancer in different prostate zones and the impact on the incidence of prostate cancer

Some triple negative breast cancers might be avoided by longer breastfeeding

As EGFR internalization is decreased, BUB1 controls EGFR signaling.

Research indicates that extended PSMA therapy is safe and effective for patients with prostate cancer.

Early-life exposure to air and light pollution linked to increased risk of pediatric thyroid cancer

More pain, more gain? New biopsy technique found to improve prostate cancer detection

Children with rare gliomas have new hope thanks to clinical trial results.

Recommended Articles For You

What You Need to Know about Hairy Cell Leukemia: A Comprehensive Guide  

Artificial Intelligence in Oncology: Current Trends, Challenges and Future Outlook 

Managing High Potassium Levels: A Comprehensive Guide to Veltassa  

Esophageal Cancer Survival Rates and Outcomes: Evidence-Based Insights from Oncology Studies 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Kate Middleton Reaches Cancer Treatment Milestone

2.

Lesser-known lobular breast cancer on the rise in U.S. women

3.

Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?

4.

When Healthcare Chatbots Fall Short of Human Connection

5.

Discovery of breast cancer treatment resistance mechanism could lead to new hope for some

1.

Oncolytic Viruses in Breast Cancer: Unlocking Synergy with Novel Combination Therapies

2.

Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results

3.

Malignant Prolactinoma: Prolactin Surge with Minimal Growth Masks Widespread Metastases

4.

The Journey Beyond Treatment: Empowering Cancer Survivorship with Technology and Artificial Intelligence

5.

The Importance of Balanced Potassium Levels in Maintaining Good Health

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Newer Immunotherapies for Myeloma- A Comprehensive Overview

2.

What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?

3.

Updates on Standard V/S High Risk Myeloma Treatment

4.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI

5.

A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot